Drug Type CAR-T |
Synonyms CART-BCMA (Shanghai Simnova Biotechnology), SNC-102, SNC102 |
Target |
Mechanism BCMA inhibitors(B-cell maturation protein inhibitors), Gene transference, T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Relapse multiple myeloma | Phase 1 | CN | 12 Mar 2021 |
Phase 1 | 15 | lxawzvmuzc(qevznricjk) = ydflntiqsk pgnvruqutq (bnzlzqnsgt, 78.20% - 100.00) View more | - | 10 Dec 2023 |